Showing results (61-70 of 176) with videos related to
Sort By:
Pageof 18
Journal of Computer-Aided Molecular Design|October 5, 2011
Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculationsHaralambos Tzoupis, Georgios Leonis, Serdar Durdagi, et al.European Journal of Medicinal Chemistry|May 5, 2009
Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseasesAggeliki Politi, Serdar Durdagi, Panagiota Moutevelis-Minakakis, et al.Brain Sciences|December 24, 2021
Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with MannanJohn M Matsoukas, Irene Ligielli, Christos T Chasapis, et al.Journal of Medicinal Chemistry|May 25, 2012
Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculationsHaralambos Tzoupis, Georgios Leonis, Grigorios Megariotis, et al.Archives of Toxicology|November 7, 2024
Zinc and its binding proteins: essential roles and therapeutic potentialDespoina P Kiouri, Christos T Chasapis, Thomas Mavromoustakos, et al.Molecules (Basel, Switzerland)|November 13, 2025
Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and CardioprotectionErrikos Petsas, Despoina P Kiouri, Nikitas Georgiou, et al.Molecules (Basel, Switzerland)|February 27, 2026
Correction: Petsas et al. Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection. <i>Molecules</i> 2025, <i>30</i>, 4240Errikos Petsas, Despoina P Kiouri, Nikitas Georgiou, et al.Current Medicinal Chemistry|March 22, 2016
Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) InhibitorsEleni Vrontaki, Georgia Melagraki, Eleanna Kaffe, et al.Molecules (Basel, Switzerland)|January 28, 2021
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 TherapyJohn Matsoukas, Vasso Apostolopoulos, Anthony Zulli, et al.Molecules (Basel, Switzerland)|June 19, 2024
Synthesis of Thiazolidin-4-Ones Derivatives, Evaluation of Conformation in Solution, Theoretical Isomerization Reaction Paths and Discovery of Potential Biological TargetsNikitas Georgiou, Danai Karta, Antigoni Cheilari, et al.Pageof 18